Skip to content

November 19, 2019

Inhofe Praises Senate Passage of Hong Kong Bills

U.S. Sen. Jim Inhofe (R-Okla.) praised the Senate passage of the Hong Kong Human Rights and Democracy Act and legislation that would prohibit the commercial export of certain munitions to the Communist party-controlled Hong Kong Police Force. Inhofe is a cosponsor of both bills.

“The front line of freedom’s cause is in the streets of Hong Kong. We are inspired by the courage of Hong Kongers who have demanded respect for their dignity and human rights. And we are appalled by the increasing brutality of the Chinese Communist Party and its henchmen. Tonight, the Senate refused to stand by while the Communist Party inflicts violence upon peaceful democratic protestors in an attempt to force the people of Hong Kong to accept the erosion of the autonomy they were promised. Unanimously passing this legislation tonight makes it clear: we will hold Beijing accountable for their human rights abuses and disregard for the rule of law in Hong Kong.” 


Last Tuesday, Inhofe took to the Senate floor to talk about how everything he warned about China doing in 2000 came true, and looking ahead at specific areas of concern with China.

This speech builds off a letter he sent to President Trump with Senator Wicker, urging the president to hold Chinese technology companies accountable, and a letter to the U.S. International Trade Commission, urging action against manipulative Chinese trade tactics. It builds on his engagement in support of the protesters in Hong Kong, cosponsoring the Hong Kong Human Rights and Democracy Act, and his long-time leadership of the Taiwan Caucus where he has authored and cosponsored countless pieces of legislation in support of a vital strategic partner.

Additionally, over the last year, Inhofe’s leadership as chairman of the Armed Services Committee has been focused on implementing the National Defense Strategy, which rightfully recognizes China as a near peer competitor. Inhofe’s Senate-passed NDAA also reflects that. 

Next Article » « Previous Article